Testing effectiveness (Phase 2)Study completedNCT00107341
What this trial is testing
Bortezomib, Paclitaxel, and Carboplatin in Treating Patients With Unresectable, Metastatic Cancer of the Esophagus or Gastroesophageal Junction
Who this might be right for
Esophageal Cancer
Alliance for Clinical Trials in Oncology 37